This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Global Pharmaceutical Regulatory Affairs Summit
22-24 October 2024
Sheraton Brussels Airport, BrusselsHybrid Event

Alastair Nixon
Director, Publishing at GlaxoSmithKline Research & Development Limited, UK


Alastair has worked in various roles in pharmaceutical product development, before moving into regulatory publishing at a major clinical research organisation. He then headed the International Regulatory Operations function at SmithKline Beecham and GSK, and as Director of Publishing, he led the UK based publishing team, working on the implementation of eCTD in the company. Alastair is now Director, Submission Standards at GSK, responsible for ensuring that GSK’s strategy with respect to electronic submissions and IDMP is aligned with external requirements. He is a member of the EFPIA IDMP Sub Group of ERAO and active on several European projects, such as eAF and Digital Application Dataset Integration (DADI). Alastair has a BSc (Hons) in Applied Chemistry from the University of Aston in Birmingham.

Agenda Sessions

  • eAF: The Current State of Play

  • Determining the Intersection between eCTD and IDMP